Vivos (RDGL) Operating Expenses (2010 - 2025)
Vivos (RDGL) reported Operating Expenses of $1.1 million for Q4 2025, up 66.43% on a YoY basis from $656515.0 in Q4 2024, and up 110.84% sequentially from $518208.0 in Q3 2025.
Vivos (RDGL) Operating Expenses (2010 - 2025) Analysis & Trends
Vivos (RDGL) has 16 years of Operating Expenses data on file, last reported at $1.1 million in Q4 2025.
- For the quarter ending Q4 2025, Operating Expenses rose 66.43% year-over-year to $1.1 million; the trailing twelve-month figure through Dec 2025 stood at $3.1 million (up 19.37% YoY), and the FY2025 full-year result was $3.1 million, up 19.37% from the prior year.
- Operating Expenses rose to $1.1 million in Q4 2025, from $518208.0 in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $1.9 million in Q2 2021 to a low of $203470.0 in Q3 2021.
- A 5-year average of $676197.7 and a median of $675574.0 in 2023 frame the typical range for Operating Expenses.
- Across the five-year window, Operating Expenses soared 1343.08% in 2021 and slumped 67.42% in 2023, its largest moves.
- Tracing RDGL's Operating Expenses over 5 years: stood at $212440.0 in 2021, then soared by 230.18% to $701426.0 in 2022, then surged by 33.13% to $933791.0 in 2023, then retreated by 29.69% to $656515.0 in 2024, then soared by 66.43% to $1.1 million in 2025.
- Business Quant data shows RDGL's Operating Expenses at $1.1 million in Q4 2025, $518208.0 in Q3 2025, and $640019.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.03 Bn | 6.27 Bn | 9.82 Bn |
| 2 | Stryker | 128.82 Bn | 125.95 Bn | 3.81 Bn | 2.87 Bn |
| 3 | Medtronic | 108.46 Bn | 99.24 Bn | 6.41 Bn | 3.59 Bn |
| 4 | Boston Scientific | 68.25 Bn | 66.79 Bn | 3.61 Bn | 2.51 Bn |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | 785.50 Mn |
| 6 | Dexcom | 28.55 Bn | 27.43 Bn | 750.30 Mn | 495.00 Mn |
| 7 | GE HealthCare Technologies | 28.51 Bn | 26.22 Bn | 1.98 Bn | 1.46 Bn |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - | -47.00 Mn |
| 9 | Koninklijke Philips | 25.42 Bn | 22.29 Bn | 2.07 Bn | -668.50 Mn |
| 10 | Vivos | 27.30 Mn | 25.74 Mn | -3,105.00 | 1.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.09 Mn |
| Sep 30, 2025 | 518,208.00 |
| Jun 30, 2025 | 640,019.00 |
| Mar 31, 2025 | 854,449.00 |
| Dec 31, 2024 | 656,515.00 |
| Sep 30, 2024 | 844,226.00 |
| Jun 30, 2024 | 525,029.00 |
| Mar 31, 2024 | 575,629.00 |
| Dec 31, 2023 | 933,791.00 |
| Sep 30, 2023 | 694,633.00 |
| Jun 30, 2023 | 911,905.00 |
| Mar 31, 2023 | 246,782.00 |
| Dec 31, 2022 | 701,426.00 |
| Sep 30, 2022 | 270,530.00 |
| Jun 30, 2022 | 796,020.00 |
| Mar 31, 2022 | 757,493.00 |
| Dec 31, 2021 | 212,440.00 |
| Sep 30, 2021 | 203,470.00 |
| Jun 30, 2021 | 1.85 Mn |
| Mar 31, 2021 | 235,090.00 |